These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Correlation of pharmacokinetic parameters to efficacy of antibiotics: relationships between serum concentrations, MIC values, and bacterial eradication in patients with gram-negative pneumonia. Schentag JJ. Scand J Infect Dis Suppl; 1990; 74():218-34. PubMed ID: 2097710 [Abstract] [Full Text] [Related]
4. Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia. Siempos II, Vardakas KZ, Manta KG, Falagas ME. Eur Respir J; 2007 Mar; 29(3):548-60. PubMed ID: 17329491 [Abstract] [Full Text] [Related]
5. Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia. Drusano GL, Preston SL, Fowler C, Corrado M, Weisinger B, Kahn J. J Infect Dis; 2004 May 01; 189(9):1590-7. PubMed ID: 15116294 [Abstract] [Full Text] [Related]
7. Pharmacist-managed aminoglycoside therapy in combination with a beta-lactam agent in the treatment of nosocomial pneumonia in critically ill patients. Wade WE, McCall CY. Pharmacotherapy; 1995 Dec 01; 15(2):216-9. PubMed ID: 7624269 [Abstract] [Full Text] [Related]
8. Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept. Roberts JA, Ulldemolins M, Roberts MS, McWhinney B, Ungerer J, Paterson DL, Lipman J. Int J Antimicrob Agents; 2010 Oct 01; 36(4):332-9. PubMed ID: 20685085 [Abstract] [Full Text] [Related]
11. Current guidelines for the treatment of severe pneumonia and sepsis. Bodmann KF. Chemotherapy; 2005 Aug 01; 51(5):227-33. PubMed ID: 16103664 [Abstract] [Full Text] [Related]
12. Antimicrobial action and pharmacokinetics/pharmacodynamics: the use of AUIC to improve efficacy and avoid resistance. Schentag JJ. J Chemother; 1999 Dec 01; 11(6):426-39. PubMed ID: 10678784 [Abstract] [Full Text] [Related]
15. Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis. Zelenitsky SA, Harding GK, Sun S, Ubhi K, Ariano RE. J Antimicrob Chemother; 2003 Oct 01; 52(4):668-74. PubMed ID: 12951354 [Abstract] [Full Text] [Related]
16. Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections. Ambrose PG, Grasela DM, Grasela TH, Passarell J, Mayer HB, Pierce PF. Antimicrob Agents Chemother; 2001 Oct 01; 45(10):2793-7. PubMed ID: 11557471 [Abstract] [Full Text] [Related]
17. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. De Jongh R, Hens R, Basma V, Mouton JW, Tulkens PM, Carryn S. J Antimicrob Chemother; 2008 Feb 01; 61(2):382-8. PubMed ID: 18070831 [Abstract] [Full Text] [Related]